BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24598415)

  • 1. SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.
    Hemachandra LP; Patel H; Chandrasena RE; Choi J; Piyankarage SC; Wang S; Wang Y; Thayer EN; Scism RA; Michalsen BT; Xiong R; Siklos MI; Bolton JL; Thatcher GR
    Cancer Prev Res (Phila); 2014 May; 7(5):505-15. PubMed ID: 24598415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells.
    Kastrati I; Edirisinghe PD; Hemachandra LP; Chandrasena ER; Choi J; Wang YT; Bolton JL; Thatcher GR
    PLoS One; 2011; 6(11):e27876. PubMed ID: 22140478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.
    Yu B; Dietz BM; Dunlap T; Kastrati I; Lantvit DD; Overk CR; Yao P; Qin Z; Bolton JL; Thatcher GR
    Mol Cancer Ther; 2007 Sep; 6(9):2418-28. PubMed ID: 17876041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
    Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
    PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells.
    Okoh VO; Felty Q; Parkash J; Poppiti R; Roy D
    PLoS One; 2013; 8(2):e54206. PubMed ID: 23437041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.
    Liu H; Bolton JL; Thatcher GR
    Chem Res Toxicol; 2006 Jun; 19(6):779-87. PubMed ID: 16780356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.
    Fan P; Craig Jordan V
    Steroids; 2014 Nov; 90():44-52. PubMed ID: 24930824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene.
    Overk CR; Peng KW; Asghodom RT; Kastrati I; Lantvit DD; Qin Z; Frasor J; Bolton JL; Thatcher GR
    ChemMedChem; 2007 Oct; 2(10):1520-6. PubMed ID: 17654759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective estrogen receptor modulator delivery of quinone warheads to DNA triggering apoptosis in breast cancer cells.
    Peng KW; Wang H; Qin Z; Wijewickrama GT; Lu M; Wang Z; Bolton JL; Thatcher GR
    ACS Chem Biol; 2009 Dec; 4(12):1039-49. PubMed ID: 19839584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
    Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
    J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland.
    Peano BJ; Crabtree JS; Komm BS; Winneker RC; Harris HA
    Endocrinology; 2009 Apr; 150(4):1897-903. PubMed ID: 19022889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of selective estrogen receptor modulators on the vagina and its supportive tissues.
    Liang R; Knight K; Nolfi A; Abramowitch S; Moalli PA
    Menopause; 2016 Feb; 23(2):129-37. PubMed ID: 26382313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk.
    Williams-Brown MY; Salih SM; Xu X; Veenstra TD; Saeed M; Theiler SK; Diaz-Arrastia CR; Salama SA
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):78-86. PubMed ID: 21600284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer chemoprevention: a review of selective estrogen receptor modulators.
    Johansen AM
    Clin J Oncol Nurs; 2005 Jun; 9(3):317-20. PubMed ID: 15973842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention.
    Park WC; Jordan VC
    Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).
    Hemachandra LP; Madhubhani P; Chandrasena R; Esala P; Chen SN; Main M; Lankin DC; Scism RA; Dietz BM; Pauli GF; Thatcher GR; Bolton JL
    Cancer Prev Res (Phila); 2012 Jan; 5(1):73-81. PubMed ID: 21997247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.
    Liu H; Qin Z; Thatcher GR; Bolton JL
    Chem Res Toxicol; 2007 Nov; 20(11):1676-84. PubMed ID: 17630709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of 3D MCF-12A breast cell cultures by estrogens--an in vitro model for ER-mediated changes indicative of hormonal carcinogenesis.
    Marchese S; Silva E
    PLoS One; 2012; 7(10):e45767. PubMed ID: 23056216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.